Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2026-01-06 @ 9:24 PM
Study NCT ID:
NCT01172392
Status:
UNKNOWN
Last Update Posted:
2013-03-29
First Post:
2010-07-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
Sponsor:
ANRS, Emerging Infectious Diseases
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
None
Primary Completion Date:
2015-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2015-06
Completion Date Type:
ESTIMATED
First Submit Date:
2010-07-28
First Submit QC Date:
None
Study First Post Date:
2010-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-28
Last Update Post Date:
2013-03-29
Last Update Post Date Type:
ESTIMATED